What is The TRUE BACK?
The TRUE BACK operates at the intersection of consumer health and orthopedic technology, providing a non-powered traction device engineered to mitigate chronic back pain, sciatica, and postural dysfunction. By focusing on a portable, adjustable, and user-centric design, the company addresses a critical demand for accessible, non-invasive pain relief. Its market position is reinforced by a commitment to customer satisfaction, evidenced by its 90-day guarantee and streamlined domestic logistics, which collectively serve to differentiate the brand from traditional medical device manufacturers.
How much funding has The TRUE BACK raised?
The TRUE BACK has raised a total of $51K across 1 funding round:
Debt
$51K
Debt (2025): $51K, investors not publicly disclosed
Key Investors in The TRUE BACK
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for The TRUE BACK?
With the recent influx of expansion capital, The TRUE BACK is poised to accelerate its growth strategy, likely focusing on broader market penetration and supply chain optimization. As the company transitions through its current Series B/C stage, the focus will shift toward scaling production capabilities and enhancing its digital footprint to reach a wider demographic of individuals suffering from musculoskeletal discomfort. Strategic priorities will likely include diversifying the product portfolio and strengthening brand equity to maintain a competitive edge in the rapidly evolving orthopedic wellness landscape.
See full The TRUE BACK company page
